Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Valerian G. Kucheryanu"'
Autor:
Irina A. Denisova, Tatiana V. Chubarova, Irina E. Bogatova, Sergei A. Vartanov, Valerian G. Kucheryanu, Viсtor M. Polterovich, Natalia A. Turdyeva, Marina V. Shakleina
Publikováno v:
Население и экономика, Vol 4, Iss 3, Pp 111-127 (2020)
Neurodegenerative diseases, Parkinson disease among them, set challenges to modern societies both in terms of premature deaths and resources spent on treatment of the diseases. At that, preventive care and early diagnostics in particular are potentia
Externí odkaz:
https://doaj.org/article/839a1516f1c84e1097dd54a9a5f3f066
Autor:
Valeria V. Goloborshcheva, Valerian G. Kucheryanu, Natalia A. Voronina, Ekaterina V. Teterina, Aleksey A. Ustyugov, Sergei G. Morozov
Publikováno v:
Biomedicines, Vol 10, Iss 9, p 2278 (2022)
Parkinson’s disease (PD) is one of the key neurodegenerative disorders caused by a dopamine deficiency in the striatum due to the death of dopaminergic (DA) neurons of the substantia nigra pars compacta. The initially discovered A53T mutation in th
Externí odkaz:
https://doaj.org/article/4a66804b54b74513b1d7d09f95e814d3
Autor:
Elena A. Katunina, Victor Blokhin, Marina R. Nodel, Ekaterina N. Pavlova, Alexander L. Kalinkin, Valerian G. Kucheryanu, Leyla Alekperova, Marianna V. Selikhova, Mikhail Yu. Martynov, Michael V. Ugrumov
Publikováno v:
International Journal of Molecular Sciences; Volume 24; Issue 3; Pages: 1842
Parkinson’s disease (PD) is diagnosed many years after its onset, under a significant degradation of the nigrostriatal dopaminergic system, responsible for the regulation of motor function. This explains the low effectiveness of the treatment of pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab823cc4634aa454ca947e168c82cd34
https://doi.org/10.3390/ijms24031842
https://doi.org/10.3390/ijms24031842
Publikováno v:
Molecular Neurobiology. 54:3618-3632
A crucial event in the pathogenesis of Parkinson's disease is the death of dopaminergic neurons of the nigrostriatal system, which are responsible for the regulation of motor function. Motor symptoms first appear in patients 20-30 years after the ons
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc5cd769797ec1f2d67f661e0f77c877
https://doi.org/10.1007/s12035-016-9936-9
https://doi.org/10.1007/s12035-016-9936-9